Abstract:The conceptual foundation of the genome-wide association study (GWAS) has advanced unchecked since its conception. A revision might seem premature as the potential of GWAS has not been fully realized. Multiple technical and practical limitations need to be overcome before GWAS can be fairly criticized. But with the completion of hundreds of studies and a deeper understanding of the genetic architecture of disease, warnings are being raised. The results compiled to date indicate that risk-associated variants lie predominantly in noncoding regions of the genome. Additionally, alternative methodologies are uncovering large and heterogeneous sets of rare variants underlying disease. The fear is that, even in its fulfillment, the current GWAS paradigm might be incapable of dissecting all kinds of phenotypes. In the following text, we review several initiatives that aim to overcome these limitations. The overarching theme of these studies is the inclusion of biological knowledge to both the analysis and interpretation of genotyping data. GWAS is uninformed of biology by design and although there is some virtue in its simplicity, it is also its most conspicuous deficiency. We propose a framework in which to integrate these novel approaches, both empirical and theoretical, in the form of a genome-wide regulatory network (GWRN). By processing experimental data into networks, emerging data types based on chromatin immunoprecipitation are made computationally tractable. This will give GWAS re-analysis efforts the most current and relevant substrates, and root them firmly on our knowledge of human disease.

The Role of Family-Based Designs in Genome-Wide Association Studies

Genome-wide association studies have problems due to confounding: Are family-based designs the answer?

Principles for the post-GWAS functional characterization of cancer risk loci

Gene‐based association tests in family samples using GWAS summary statistics

Principles for the Post-Gwas Functional Characterisation of Risk Loci

Layers of epistasis: genome‐wide regulatory networks and network approaches to genome‐wide association studies

Univariate/Multivariate Genome-Wide Association Scans Using Data from Families and Unrelated Samples

Gene and Pathway-Based Analysis: Second Wave of Genome-wide Association Studies

Gene and Pathway-Based Second-Wave Analysis of Genome-Wide Association Studies

An Overview of Genome-Wide Association Studies.

GWAS 2011: Opportunities and Challenges

Strategies for Pathway Analysis Using GWAS and WGS Data

Chapter 11: Genome-Wide Association Studies

A dynamic model for genome-wide association studies

Research Strategies for the Next Step of Genome-Wide Association Study

Translation of genome-wide association study: from genomic signals to biological insights

Leveraging local identity-by-descent increases the power of case/control GWAS with related individuals

Strategies for Pathway Analysis from GWAS Data

Benefits and limitations of genome-wide association studies

Structures and Assumptions: Strategies to Harness Gene $\times$ Gene and Gene $\times$ Environment Interactions in GWAS

Interpreting disease genome‐wide association studies and polygenetic risk scores given eligibility and study design considerations